US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist
  • 3.880
  • +0.120+3.19%
Close Jul 5 16:00 ET
21.07MMarket Cap-1182P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aprea Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.67

+50.00%
Analyst Rating

Buy

Jun 30, 2024

Aprea Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 50.000K--
--2024/Q2-- / 33.330K--
--2024/Q1380.570K / 0.000--
--2023/Q414.080K / 100.000K--
--2023/Q3319.470K / 83.330K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 50.000K--
--2024/Q2-- / 33.330K--
--2024/Q1380.570K / 0.000--
--2023/Q414.080K / 100.000K--
--2023/Q3319.470K / 83.330K--

Unlock Free Earnings Estimates

Aprea Therapeutics Earnings Reports

  • Aprea Therapeutics | 10-Q: Quarterly report

    May 14 08:39 ET

  • Aprea Therapeutics | 10-K: Annual report

    Mar 26 07:49 ET

  • Aprea Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:10 ET

  • Aprea Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 07:39 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg